Natera insider trading
NTRAfinancial statementsForm 4 filings on EDGAR1,139 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Natera bought $0 of stock in the open market, and 7 sold $107M. Officers and directors accounted for $0 of purchases and $107M of sales. The last reported transaction was an open-market sale by Brophy Michael Burkes on October 30, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 30, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $107MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
1,139 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | open-market sale10b5-1 | 1,906 | $425.55 | $811K | 46,574 | Oct 30, 2026 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | open-market sale10b5-1 | 313 | $425.32 | $133K | 49,345 | Oct 30, 2026 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | open-market sale10b5-1 | 865 | $426.87 | $369K | 48,480 | Oct 30, 2026 |
| Oct 28, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 187 | $426.34 | $80K | 217,686 | Oct 29, 2026 |
| Oct 28, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | open-market sale10b5-1 | 968 | $426.34 | $413K | 168,221 | Oct 29, 2026 |
| Oct 28, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | open-market sale10b5-1 | 1,162 | $426.34 | $495K | 104,742 | Oct 29, 2026 |
| Oct 28, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | open-market sale10b5-1 | 898 | $426.34 | $383K | 195,578 | Oct 29, 2026 |
| Oct 28, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT, Director | open-market sale10b5-1 | 3,430 | $426.34 | $1M | 91,232 | Oct 29, 2026 |
| Oct 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | open-market sale10b5-1 | 1,198 | $426.34 | $511K | 49,658 | Oct 29, 2026 |
| Oct 27, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 291 | $406.00 | $118K | 217,873 | Oct 29, 2026 |
| Oct 27, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 1,718 | $406.00 | $698K | 2M | Oct 29, 2026 |
| Oct 27, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | open-market sale10b5-1 | 884 | $406.00 | $359K | 169,189 | Oct 29, 2026 |
| Oct 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | open-market sale10b5-1 | 1,010 | $406.00 | $410K | 105,904 | Oct 29, 2026 |
| Oct 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | open-market sale10b5-1 | 781 | $406.00 | $317K | 196,476 | Oct 29, 2026 |
| Oct 27, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT, Director | open-market sale10b5-1 | 2,264 | $406.00 | $919K | 94,662 | Oct 29, 2026 |
| Oct 27, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | open-market sale10b5-1 | 781 | $406.00 | $317K | 50,856 | Oct 29, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 200 | $406.50 | $81K | 221,114 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 962 | $408.26 | $393K | 220,152 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 627 | $409.89 | $257K | 219,525 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 605 | $411.32 | $249K | 218,920 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 211 | $412.20 | $87K | 218,709 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 125 | $413.05 | $52K | 218,584 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 255 | $415.67 | $106K | 218,329 | Oct 23, 2026 |
| Oct 21, 2026 | Sheena Jonathan | Director | open-market sale10b5-1 | 165 | $416.67 | $69K | 218,164 | Oct 23, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 215 | $399.34 | $86K | 8,785 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 280 | $401.29 | $112K | 8,505 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 90 | $404.25 | $36K | 8,415 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 50 | $405.15 | $20K | 8,365 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 35 | $406.63 | $14K | 8,330 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 80 | $409.36 | $33K | 8,250 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 142 | $398.95 | $57K | 8,858 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 280 | $400.68 | $112K | 8,578 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 60 | $401.62 | $24K | 8,518 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 90 | $403.70 | $36K | 8,428 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 80 | $406.06 | $32K | 8,348 | Oct 20, 2026 |
| Oct 16, 2026 | Sheena Jonathan | Director | open-market sale10b5-1indirect | 98 | $409.34 | $40K | 8,250 | Oct 20, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | option exercise | 50,000 | $10.41 | $521K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 286 | $388.32 | $111K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 714 | $389.84 | $278K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 600 | $390.21 | $234K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 300 | $391.58 | $117K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 800 | $393.47 | $315K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 300 | $394.39 | $118K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 1,900 | $396.30 | $753K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 1,100 | $397.16 | $437K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 600 | $398.09 | $239K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 793 | $399.31 | $317K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 2,671 | $400.31 | $1M | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 5,974 | $401.42 | $2M | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | open-market sale10b5-1 | 6,309 | $402.23 | $3M | 2M | Oct 16, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN, Director | Oct 27, 2026 | open-market sale | 2M | — | $143M (111) | 111 of 111 |
| Chapman Steven Leonard | CEO AND PRESIDENT, Director | Oct 28, 2026 | open-market sale | 91,232 | — | $92M (53) | 53 of 53 |
| Botha Roelof | Director | Jun 26, 2026 | award | 4,465 | — | $35M (17) | 0 of 17 |
| Sheena Jonathan | Director | Oct 28, 2026 | open-market sale | 217,686 | — | $31M (154) | 154 of 154 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Oct 28, 2026 | open-market sale | 104,742 | — | $24M (63) | 62 of 63 |
| Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Oct 28, 2026 | open-market sale | 168,221 | — | $24M (40) | 40 of 40 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Oct 30, 2026 | open-market sale | 46,574 | — | $22M (33) | 33 of 33 |
| Rosenman Herm | Director | Jun 26, 2026 | award | 5,821 | — | $15M (5) | 1 of 5 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Oct 28, 2026 | open-market sale | 195,578 | — | $10M (17) | 17 of 17 |
| Baynes Roy D. | Director | Jun 26, 2026 | award | 20,083 | — | $3M (8) | 8 of 8 |
| Marcus Gail Boxer | Director | Jun 26, 2026 | award | 7,754 | — | $2M (5) | 1 of 5 |
| Chapman Rowan E | Director | Jul 15, 2026 | open-market sale | 4,663 | — | $2M (5) | 3 of 5 |
| Bertagnolli Monica | Director | Jun 26, 2026 | award | 6,945 | — | — | — |
| Williams Brinkley Ruth | Director | Apr 24, 2026 | award | 5,475 | — | — | — |
| Rubin Eric H | Director | Jun 26, 2026 | award | 2,204 | — | — | — |
| Healy James | Director | Apr 25, 2025 | award | 46,260 | — | — | — |
| Lynch Thomas J. Jr. | Director | Jun 26, 2026 | award | 1,905 | — | — | — |
Questions
Are Natera insiders buying or selling?
Over the twelve months to November 1, 2026, 12 insiders at Natera sold $402M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $402M. Only open-market purchases and sales are counted.
Who sold the most Natera stock in the last year?
Rabinowitz Matthew (EXECUTIVE CHAIRMAN, Director) sold $143M in 111 open-market sales over the twelve months to November 1, 2026.
Do Natera executives sell under 10b5-1 plans?
483 of the 511 open-market sales in the last twelve months (95%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Natera
- Natera financial statements
- 2 tracked funds holding NTRA
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.